Oral Cobalamin Supplementation in Dogs with Chronic Enteropathies and Hypocobalaminemia
Main Authors: | Toresson, L., Steiner, J.M., Suchodolski, J.S., Spillmann, T. |
---|---|
Format: | Online |
Language: | English |
Published: |
John Wiley and Sons Inc.
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913667/ |
Similar Items
-
S100A12 concentrations and myeloperoxidase activities are increased in the intestinal mucosa of dogs with chronic enteropathies
by: Mohsen Hanifeh, et al.
Published: (2018-04-01) -
Prevalence of food-responsive enteropathy among dogs with chronic enteropathy
in Japan
by: KAWANO, Koji, et al.
Published: (2016) -
Cyclooxygenase‐2 and 5‐Lipoxygenase in Dogs with Chronic Enteropathies
by: Dumusc, S.D., et al.
Published: (2014) -
Urinary and faecal N-methylhistamine concentrations do not serve as markers for mast cell activation or clinical disease activity in dogs with chronic enteropathies
by: Anfinsen, Kristin P, et al.
Published: (2014) -
A Prospective, Placebo‐Controlled Pilot Evaluation of the Effect of Omeprazole on Serum Calcium, Magnesium, Cobalamin, Gastrin Concentrations, and Bone in Cats
by: Gould, E., et al.
Published: (2016)